Flagship Ventures Fund V L.P. 13D and 13G filings for Evelo Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-13 5:00 pm Purchase |
2023-07-11 | 13D | Evelo Biosciences, Inc. EVLO |
Flagship Ventures Fund V L.P. | 7,932,624 42.200% |
7,932,624 (New Position) |
Filing |